Overview

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Status:
Terminated
Trial end date:
2020-08-25
Target enrollment:
Participant gender:
Summary
The objective of this exploratory study is to evaluate the cellular and connective tissue composition of joints from patients with Osteoarthritis (OA) who have been treated with fasinumab, compared with those treated with placebo or Non-steroidal anti-inflammatory drugs (NSAIDs).
Phase:
Phase 2
Details
Lead Sponsor:
Regeneron Pharmaceuticals
Collaborator:
Teva Pharmaceutical Industries, Ltd.
Treatments:
Celecoxib
Diclofenac
Fasinumab
Naproxen